Related Experiment Video

Updated: Jun 1, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Management of antibiotic-resistant infection in the newborn

James William Gray1, Mitul Patel

  • 1Department of Microbiology, Birmingham Women's Hospital, Edgbaston, UK. james.gray@bwhct.nhs.uk

Archives of Disease in Childhood. Education and Practice Edition
|May 19, 2011
PubMed

Insights

The rise of multidrug-resistant bacteria, especially Gram-negative strains, presents a critical challenge in neonatal care. Current treatment options are limited, necessitating research into effective management strategies for these infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Neonatal Care

Background:

  • Multidrug-resistant bacteria are increasingly prevalent globally.
  • Gram-positive resistance has been managed with new antibiotics like linezolid and daptomycin.
  • Emergence of multidrug-resistant Gram-negative bacteria, including carbapenem-resistant strains, poses a significant threat.

Purpose of the Study:

  • To review the current landscape of antibiotic resistance in neonatal infections.
  • To discuss the challenges and limitations in treating multidrug-resistant Gram-negative bacterial infections in neonates.
  • To highlight the need for optimal management strategies for these serious infections.

Main Methods:

  • Review of current literature on antibiotic resistance patterns in neonatal infections.
  • Analysis of treatment options for Gram-positive and Gram-negative bacterial infections in neonates.
  • Discussion of the clinical implications of multidrug-resistant organisms in neonatal intensive care units.

Main Results:

  • Vancomycin remains effective for most Gram-positive infections, with new agents available.
  • Treatment options for multidrug-resistant Gram-negative bacteria are severely limited.
  • Older antibiotics like colistin are being reconsidered due to lack of alternatives.

Conclusions:

  • While Gram-positive resistance is being addressed, multidrug-resistant Gram-negative bacteria present a more urgent challenge in neonates.
  • Effective management strategies for serious neonatal infections caused by multidrug-resistant Gram-negative bacteria require further determination.
  • Continued research and development of novel therapeutic approaches are crucial.

More Related Videos

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...